Company Overview of Isto Biologics
Isto Biologics develops orthobiologic products for spine, orthopedics, and sports medicine. It offers InQu, a bone graft extender and substitute; Influx, a trabecular bone graft; CellPoint, a concentrated bone marrow aspirate system; NuQu, a cell-based therapy for disc regeneration; and RevaFlex, a regenerative cartilage technology. Its products are used by patients suffering from debilitating pain and loss of mobility. Isto Biologics was formerly known as ISTO Technologies, Inc. and changed its name to Isto Biologics in October 2016. The company was founded in 1997 and is based in St. Louis, Missouri with operations in Massachusetts.
1155 Olivette Executive Parkway
St. Louis, MO 63132
Founded in 1997
Key Executives for Isto Biologics
Isto Biologics Key Developments
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
October 19, 2016
|Arteriocyte Medical Systems, Inc.|
June 13, 2016
|Isto Biologics, Commercial Business|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Isto Biologics, please visit www.istobiologics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.